在肺切除术后的带有支气管多气管的肺气中,加速治疗概念
Gian-Marco Monsch1, Harry Etienne1, Sven Hillinger1
1Department of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Scientific reports
|December 31, 2024
概括
这项研究表明,肺切除术后的加速治疗是有效的,即使有支气管. 该方法实现了百分之百的empyema解决,在复杂的病例中证明了安全性和有效性.
科学领域:
- 胸部外科手术 胸部外科手术
- 手术创新 在外科创新.
- 关键护理医学 关键护理医学
背景情况:
- 肺切除术后的肺带来了重大治疗挑战,特别是当它被支气管囊复杂化时.
- 现有的治疗策略往往涉及长期管理,并且可能具有不同的结果.
研究的目的:
- 为了评估一个加速治疗概念的临床结果,对于 postpneumonectomy empyema.
- 为了比较这种加快方法在患有和没有支气管的患者中的疗效和安全性.
主要方法:
- 从2005年11月至2020年7月期间接受治疗的58名肺切除术后肺瘤患者的临床结果数据的回顾性分析.
- 加速治疗涉及重复的手术除菌,考虑局部区域片,负压伤口治疗和抗生素溶液灌注.
- 患者被分为两组:A组 (有支气管) 和B组 (没有支气管).
主要成果:
- 总体30天死亡率为15.5% (9名患者),两组死亡率相似 (A组15.8%,B组15.4%).
- 加速治疗在整个队列中实现了百分之百的empyema解决,A组的复发率为15.8%,B组为7.7%.
- 虽然没有统计学意义,但90天死亡率在A组 (15.8%) 与B组 (28.2%) 相比,往往较低,平均住院时间在两组之间是可比的.
结论:
- 加快治疗概念是有效和安全的管理肺切除术后的肺,包括支气管多气管的病例.
- 这种方法成功地解决了,同时保持了胸壁的完整性.
- 该研究支持使用这种加速策略来治疗复杂的肺切除术后肺病例.
相关概念视频
01:26Flail Chest-II
160
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
160
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:28Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
01:30Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
01:28Pleural Effusion II: Symptoms and Management
154
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
154